Proceedings of the 5th International Conference on Neuroscience, Neurology and Psychiatry (ICONAP 2022)

<Previous Article In Volume
Next Article In Volume>

Attitude Toward Treatment and Medication Adherence Among Chronic Schizophrenia After Undergoing Confinement

Authors
Jenny Marlindawani Purba1, *, Hasnida Hasnida2, Iwan Rusdi1
1Faculty of Nursing, Universitas Sumatera Utara, Medan, Indonesia
2Faculty of Psychology, Universitas Sumatera Utara, Medan, Indonesia
*Corresponding author. Email: jenny_marlindawani@usu.ac.id
Corresponding Author
Jenny Marlindawani Purba
Available Online 31 March 2023.
DOI
10.2991/978-94-6463-120-3_18How to use a DOI?
Keywords
attitude; medication adherence; schizophrenia; confinement
Abstract

Medication adherence is a crucial aspect in preventing relapse in chronic schizophrenic patients. Positive attitude towards medication adherence is one of the contributing factors in medication adherence. Objective: This study aimed to analyse the relationship between attitude toward treatment and medication adherence among persons with chronic schizophrenia after undergoing confinement. Method: Design of the study was a correlation study then analysed by Pearson Product Moment Correlation. Sixty patients were recruited by consecutive sampling from community health center Sumatera Utara Province. Correlation of attitude toward treatment with medication adherence was examined by Pearson Product Moment Correlation. Results: Current attitudes of people with chronic schizophrenia were 65.0% negative. The percentage of low adherence to treatment was 68.3%. Attitudes was strongly associated with adherence to medication (r = 0.86; p = 0.001). Conclusions: A reminding and observation family member in taking medication is important to achieve the successful of treatment. Therefore, we suggest that future intervention focused improving adherence to medication.

Copyright
© 2023 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Download article (PDF)

<Previous Article In Volume
Next Article In Volume>
Volume Title
Proceedings of the 5th International Conference on Neuroscience, Neurology and Psychiatry (ICONAP 2022)
Series
Advances in Health Sciences Research
Publication Date
31 March 2023
ISBN
978-94-6463-120-3
ISSN
2468-5739
DOI
10.2991/978-94-6463-120-3_18How to use a DOI?
Copyright
© 2023 The Author(s)
Open Access
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Cite this article

risenwbib
TY  - CONF
AU  - Jenny Marlindawani Purba
AU  - Hasnida Hasnida
AU  - Iwan Rusdi
PY  - 2023
DA  - 2023/03/31
TI  - Attitude Toward Treatment and Medication Adherence Among Chronic Schizophrenia After Undergoing Confinement
BT  - Proceedings of the 5th International Conference on Neuroscience, Neurology and Psychiatry (ICONAP 2022)
PB  - Atlantis Press
SP  - 113
EP  - 119
SN  - 2468-5739
UR  - https://doi.org/10.2991/978-94-6463-120-3_18
DO  - 10.2991/978-94-6463-120-3_18
ID  - Purba2023
ER  -